Edmonton, Canada

M Joanne Lemieux

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: University of Alberta. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: M Joanne Lemieux. Retrieved from https://idiyas.com/inventor/m-joanne-lemieux

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: M Joanne Lemieux: Innovator in RNA Virus Inhibition

Introduction

M Joanne Lemieux is a prominent inventor based in Edmonton, Canada. He has made significant contributions to the field of virology, particularly in the development of compounds that inhibit RNA virus infections. His work is crucial in the ongoing battle against viral diseases.

Latest Patents

M Joanne Lemieux holds 1 patent for his invention titled "RNA virus inhibitor compounds and uses thereof." This patent provides innovative compounds and methods for inhibiting virus infections, specifically targeting Baltimore Group IV RNA viruses. The disclosure also includes methods for treating such infections in subjects, along with pharmaceutical compositions related to these compounds.

Career Highlights

Lemieux is affiliated with the University of Alberta, where he conducts research and develops his innovative ideas. His work has garnered attention in the scientific community, contributing to advancements in antiviral therapies.

Collaborations

Throughout his career, M Joanne Lemieux has collaborated with notable colleagues, including James Nieman and D Lorne Tyrrell. These partnerships have enhanced his research and expanded the impact of his inventions.

Conclusion

M Joanne Lemieux is a key figure in the field of RNA virus research, with a focus on developing effective inhibitors. His contributions are vital for advancing treatments against viral infections, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…